Artificial intelligence for translational personalized neoantigen cancer vaccine development
Clinical progress and key translational barriers in personalized neoantigen vaccination are summarized, and AI-enabled approaches may contribute across four major stages: multi-omics integration for neoantigen discovery, processing-aware HLA presentation prediction, structure-aware and TCR-informed immunogenicity model...